Diana Bonderman

9PUBLICATIONS
60CO-AUTHORS
Gene and molecular therapyCardiology (incl. cardiovascular diseases)Respiratory diseasesExercise physiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 14, 2026
A trial emulation study indirectly comparing tafamidis and acoramidis in transthyretin amyloid cardiomyopathy: the ReplicATTR study.

|Aug 20, 2026
Validation of an Artificial Intelligence-Derived ECG Algorithm for Detecting Cardiac Amyloidosis in Patients With Heart Failure With Preserved Ejection Fraction: Clinical Application and Prognostic Implications.

|Oct 09, 2025
A review on wearable cardioverter-defibrillators in clinical practice for sudden cardiac death prevention and heart failure management.

David Duncker, Rodrigue Garcia, Diana Bonderman

|Mar 11, 2025
Macitentan for Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Pulmonary Vascular Disease: Results of the SERENADE Randomized Clinical Trial and Open-Label Extension Study.

Sanjiv J Shah, Diana Bonderman, Barry A Borlaug

|Aug 01, 2022
Riociguat in pulmonary hypertension and heart failure with preserved ejection fraction: the haemoDYNAMIC trial.

Theresa Marie Dachs, Franz Duca, René Rettl

|Jun 29, 2022
Impact of Tafamidis and Optimal Background Treatment on Physical Performance in Patients With Transthyretin Amyloid Cardiomyopathy.

Roza Badr Eslam, Begüm Öztürk, René Rettl

Pageof 2

Frequent Collaborators

4 joint publications

René Rettl

3 joint publications

Daniel Dalos

2 joint publications

Luciana Camuz Ligios

2 joint publications

Christian Hengstenberg